Edition:
United States

People: Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

12.09USD
19 Nov 2018
Change (% chg)

-- (--)
Prev Close
$12.09
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
354,288
52-wk High
$25.92
52-wk Low
$11.22

Swisher, Daniel 

Mr. Daniel N. Swisher is an Independent Director of Corcept Therapeutics Incorporated. He has been the Chief Executive Officer and a member of the Board of Sunesis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, since 2003, and its President since 2005. He joined Sunesis in 2001 and had previously served as the company’s chief business officer and chief financial officer. Prior to that, Mr. Swisher had held a broad range of senior management roles, including Senior Vice president of Sales and Marketing at ALZA Corporation, a pharmaceutical and medical systems company, from 1992 to 2001. Mr. Swisher is also Chairman of the Board of Cerus Corporation, a biopharmaceutical company, and has held this position since 2013. Mr. Swisher holds a B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business. Mr. Swisher brings to our Board experience in life science industry sales, operations and finance.

Basic Compensation

Total Annual Compensation, USD 66,542
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 232,858
Fiscal Year Total, USD 299,400

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Wilson

818,575

Joseph Belanoff

4,271,450

Gary Robb

1,780,520

Sean Maduck

2,754,740

Robert Fishman

1,130,070

G. Leonard Baker

287,691
As Of  30 Dec 2017